InnoCan Pharma's total assets for Q2 2026 were $10.35M, a decrease of -4.65% from the previous quarter. DE:IP40 total liabilities were $2.95M for the fiscal quarter, a 0.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.